Daily non-political popular news in brief.
2 drugs work better together than either alone against kidney cancer
07-30-2007 · EurekAlert!A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.
Read more »
Keywords: drugs, work, together, either, alone, kidney, cancer, drug
« Previous | Next »
Similar news on "2 drugs work better together than either alone against kidney cancer":
- First report that apoptotic and anti-angiogenic therapies work better together than alone
11-10-2006 · EurekAlert!
American researchers have found that giving a combination of imantanib and a drug that induces cell death was better at inhibiting the growth of Ewing's sarcoma in mice than either therapy on its own, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague on Friday.
Similar news · Read more »
- Drug combination proves effective against myeloma in Phase I trial
12-11-2006 · EurekAlert!
Two "new generation" drugs for the bone marrow cancer multiple myeloma may work even better together than they do individually, according to the results of a multicenter Phase I clinical trial to be presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Hematology in Orlando, Fla.
Similar news · Read more »
- Dealing deadly cancers a knockout punch
05-10-2007 · EurekAlert!
Recent studies also indicate that oncolytic viruses work synergistically with standard anti-cancer drugs, providing significantly stronger responses than either agent alone.
Similar news · Read more »
- Combining brain scans and behavioral tests aids early identification of at-risk readers
06-10-2007 · EurekAlert!
Taken together, functional brain scans and tests of reading skills strongly predict which children will have ongoing reading problems. What's more, the two methods work better together than either one alone, according to new research in the June issue of Behavioral Neuroscience, which is published by the American Psychological Association.
Similar news · Read more »
- Radiation and drug combo helps boost efficacy of lung cancer treatment
09-01-2007 · EurekAlert!
Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
Similar news · Read more »
- Annals of Internal Medicine tip sheet for Nov. 6, 2007
10-31-2007 · EurekAlert!
The following papers will be in the next issue of the Annals of Internal Medicine: "American College of Physicians Issues Comprehensive Guidelines for Diagnosis and Treatment of Stable COPD"; "Nutrient Reduces Need for Steroids in Those with Stubborn Ulcerative Colitis"; "Antipsychotic Drug Reduces Persistent Depression"; "Study Finds ACE Inhibitors and ARBs Both Control Blood Pressure"; and "ACE Inhibitors and ARBs Both Reduce Proteinuria; Together They’re More Effective Than Either Alone."
Similar news · Read more »
- Radiation and drug combo helps boost efficacy of lung-cancer treatment
09-04-2007 · UT Southwestern Medical Center
Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
Similar news · Read more »
- Weill Cornell team identifies potential new cancer drug target
06-21-2007 · EurekAlert!
Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.
Similar news · Read more »
- Combination targets: some drugs may work best when they work together
10-24-2007 · EurekAlert!
While some targeted therapies -- drugs developed to attack specific molecules in the critical chemical pathways occurring within cancer cells -- work well by themselves, increasingly researchers are finding that they work better when teamed with other targeted and conventional therapies.
Similar news · Read more »
- A new pharmaceutical drug that halts progress of metastatic kidney cancer
03-01-2007 · EurekAlert!
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.
Similar news · Read more »
